Daniel D Cummins

2 months ago | openlegalblogarchive.org | Daniel E. Cummins |Daniel D Cummins

On President’s Day – Feb. [15th] this year – we will honor the memory and accomplishments of one of our greatest presidents, Abraham Lincoln. While the myth and legend of this great president has expanded through history, it cannot be forgotten that he began his career as a country lawyer in Illinois. Over the course of his career as an attorney and during his rise as a politician, Lincoln was famous for his wit and simple, yet compelling, way with words.

Jun 24, 2024 | nature.com | Daniel D Cummins |Simon Little

AbstractQuantification of motor symptom progression in Parkinson’s disease (PD) patients is crucial for assessing disease progression and for optimizing therapeutic interventions, such as dopaminergic medications and deep brain stimulation. Cumulative and heuristic clinical experience has identified various clinical signs associated with PD severity, but these are neither objectively quantifiable nor robustly validated.

Oct 13, 2023 | thejns.org | Ramin A. Morshed |Daniel D Cummins |John Clark |Jacob Young

Share Link Copy this link, or click below to email it to a friend Email this content or copy the link directly: The link was not copied. Your current browser may not support copying via this button.

Aug 1, 2023 | thejns.org | Kim JH |Daniel D Cummins |MINH NGUYEN |Minh Nguyễn |Satvir Saggi

Keywords: genomic alterations; brain metastases; rapid progression; rapid recurrence; RB1; CTNNB1 Brain metastases are the most common intracranial tumor and occur in 10%–40% of all systemic malignancies.1,2 Patient prognosis is heterogeneous and varies depending on factors such as primary tumor type, genomic features, systemic disease status, and intracranial metastatic burden.3 Resection is indicated for single brain metastases, a dominant symptomatic lesion with limited CNS burden, and...

Aug 1, 2023 | thejns.org | Daniel D Cummins |Joseph Garcia |MINH NGUYEN |Minh Nguyễn |Satvir Saggi

Keywords: brain metastasis; seizure; CDKN2A; genetics; machine learning; tumor Seizures are a common and disabling clinical feature of brain metastases (BMs), occurring in up to 20% of patients with BMs at presentation.1,2 Seizures secondary to BMs can significantly reduce quality of life and neurocognitive function for patients.3 In patients with BMs presenting with seizures, resection can offer favorable seizure control in up to 90% of cases.4 Resection of BMs can furthermore confirm a...